Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Director John B. Bode Acquires 10,000 Shares
Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Get Free Report) Director John B. Bode acquired 10,000 shares of the stock in a transaction on Wednesday, March 19th. The stock was acquired at an average cost of $7.96 per share, for a total transaction of $79,600.00. Following the acquisition, the director now directly owns 40,000 shares in the […]
21 Mar 20:34 · The Markets Daily